Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Woo Andrew H., Director. Officer active across 1 company, notably Alzamend Neuro, Inc.. In total, 3 filings have been recorded. Activity tracked since 13 September 2021. The latest transaction was filed on 15 March 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Andrew H. Woo is a Board Member at Alzamend Neuro, Inc. He plays a key role on the board, contributing to strategic decision-making for the company. His experience and expertise are essential for overseeing operations and ensuring compliance with regulations. He helps guide the future direction of the company.